Evidence map›Paper›PMID 37996426›Full record

ArticleLight, science & applications2023

The power of light and sound: optoacoustic skin imaging for diabetes progression monitoring.

Amanda P Siegel, Kamran Avanaki

Abstract read
In one paragraph

Article in Light, science & applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amanda P SiegelRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-4112-0212
Kamran AvanakiRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, USA. avanaki@uic.edu.ORCID http://orcid.org/0000-0002-1437-8456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes progression is marked by damage to vascular and neural networks. Raster-scan optoacoustic mesoscopy holds the potential to measure extent of diabetes progression by analyzing changes in skin vasculature.

Identifiers

PMID37996426
PMCPMC10667326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.